logo

For the Inventor, By the Inventor

Zwijnaarde, Belgium

Intrexon Actobiotics N.v.

Calculating rank
USPTO Granted Patents = 27

% Expired Patents = 14.8



Trademarks = 1

Forward Citations = 26

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Lothar Steidler (20 out of 28 patents)

silverMedal Pieter Rottiers (11 out of 15 patents)

bronzeMedal Klaas Vandenbroucke (10 out of 12 patents)

4.  Karolien Van Huynegem (8 out of 8 patents)

5.  Veerle Snoeck (5 out of 24 patents)

6.  Sam Corveleyn (3 out of 3 patents)

7.  Patrick Dhaese (3 out of 3 patents)

8.  Sabine Neirynck (3 out of 4 patents)

9.  Erik Remaut (2 out of 3 patents)

10.  Dirk Iserentant (2 out of 4 patents)

11.  Klaas Vanden-Broucke (1 out of 1 patent)

12.  Sabine Neirynck (3 patents)


Core Competencies:
Genetically Modified Bacteria
IL-10
Insulin
Mucosal Delivery
Type 1 Diabetes
Cryoprotectants
Lactic Acid Bacteria
Polycistronic Expression
Modified Gram Positive Bacteria
Mucosal Tolerance
Immune Disease
Microorganism

27 patents:

1. 12359210 - Genetically modified bacteria stably expressing IL-10 and insulin (2025-07-15),
2. 12252516 - Mucoadhesive microorganism (2025-03-18),
3. 12246046 - Compositions and methods for the treatment of type 1 diabetes (2025-03-11),
4. 11786567 - Compositions and methods for the treatment of type 1 diabetes (2023-10-17),
5. 11633438 - Cryoprotectants for freeze drying of lactic acid bacteria (2023-04-25),
6. 11549118 - Genetically modified bacteria stably expressing IL-10 and insulin (2023-01-10),
7. 11384123 - Mucoadhesive microorganism (2022-07-12),
8. 10988770 - Polycistronic expression system for bacteria (2021-04-27),
9. 10905727 - Compositions and methods for the treatment of type 1 diabetes (2021-02-02),
10. 10858663 - Genetically modified bacteria stably expressing IL-10 and insulin (2020-12-08),
11. 10808014 - Mucoadhesive microorganism (2020-10-20),
12. 10793825 - Modified gram positive bacteria and uses thereof (2020-10-06),
13. 10668136 - Treatment of immune disease by mucosal delivery of antigens using genetically modified (2020-06-02),
14. 10596207 - Cryoprotectants for freeze drying of lactic acid bacteria (2020-03-24),
15. 10519418 - Modified gram positive bacteria and uses thereof (2019-12-31),
Company Overview
Intrexon Actobiotics N.V., based in Zwijnaarde, Belgium, specializes in the development of innovative biopharmaceuticals through advanced synthetic biology. The company focuses on harnessing the power of engineered organisms to create therapeutic solutions, particularly in the fields of immunotherapy and regenerative medicine. With a commitment to pioneering research, Intrexon Actobiotics aims to address unmet medical needs by leveraging cutting-edge technologies to enhance patient outcomes and improve healthcare solutions globally.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

27 Patents

#4 in Zwijnaarde

#124 in Belgium

#24,034 in the World

Zwijnaarde, BE
Zwijnaarde, Belgium

Intrexon Actobiotics N.v.

Forward Citations = 26

11 inventors:

goldMedal Lothar Steidler (20 out of 28 patents)

silverMedal Pieter Rottiers (11 out of 15 patents)

bronzeMedal Klaas Vandenbroucke (10 out of 12 patents)

4.  Karolien Van Huynegem (8 out of 8 patents)

5.  Veerle Snoeck (5 out of 24 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Intrexon Actobiotics N.v.. Retrieved from https://idiyas.com/company/intrexon-actobiotics-n-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…